To report a rare case of scrotal elephantiasis secondary to hidradenitis suppurativa, emphasizing its exceptional nature.
Key Findings:
The scrotal mass measured 20 × 16 × 6 cm and weighed approximately 6 kg. Laboratory investigations were within normal limits.
Histopathology showed reactive fibromyxoid changes without malignancy.
Interpretation:
Scrotal elephantiasis due to hidradenitis suppurativa is a rare complication indicating advanced lymphatic destruction, with significant implications for patient management.
Limitations:
The case highlights that biologic therapy may not prevent progression to end-stage lymphatic disease in refractory hidradenitis suppurativa.
Conclusion:
Early recognition and timely surgical intervention are essential to restore function and quality of life.
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
